 |
|
| ANNUAL REPORTS IN MEDICINAL CHEMISTRY, 42
| |
| | |
|
|
To order this title, and for more information, click here
John Macor, Neuroscience Discovery Chemistry, Bristol-Myers Squibb, USA
Included in series
Annual Reports in Medicinal Chemistry,
Audience
For medicinal, pharmaceutical and organic chemists
Contents
I. Central Nervous System Diseases
-Potential CNS Applications for Phosphodiesterase Enzyme Inhibitors (N. J. Brandon and D. P. Rotella)
-Recent Developments in Monoamine Reuptake Inhibitors (S. Liu and B. F. Molino)
Secretase Inhibitors and Modulators for the Treatment
of Alzheimer's Disease (R. E. Olson and L. R. Marcin)
-Recent Advances in Drug Discovery of Histamine H3 Antagonists (R. L. Hudkins,
R. Raddatz)
-Recent Advances in the Treatment of Insomnia (A. Palomer, M. Princep and A. Guglietta)
-Advances in Transient Receptor Potential
(TRP) Modulators (A. Vasudevan, M. E. Kort)
II. Cardiovascular and Metabolic Diseases
-Case History: JANUVIA (Sitagliptin), a Selective
Dipeptidyl Peptidase IV Inhibito for the Treatment of Type 2 Diabetes (A. E. Weber, N. Thornberry)
-Cathepsin K Inhibitors (W. Cameron
Black and M. David Percival)
-New Nonpeptide-Binding GPCRs as Targets for Diabetes and the Metabolic Syndrome (M. C.T.Fyfe, H. A.Overton,
M. J.Procter, C. Reynet & J. R. White)
-Novel Selective Estrogen Receptor Modulators (SERMS) (J. A. Dodge and T. I. Richardson)
-Lipid-metabolizing
enzymes as targets for dyslipidemia and insulin resistance (V. Yeh, A. S. Judd, and A. J. Souers)
-Recent Trends in HDL Modulating Therapies
(D. De and I. Khanna)
III. Inflammation / Pulmonary / GastroIntestinal Diseases
-Case History on Tegaserod (R. Giger, H. Mattes and
H.-J. Pfannkuche)
-Advances in the Discovery of CC Chemokine Receptor-2 Atagonists (P. Carter, R. Cherney, I. K.Mangion)
-Semicarbazide
Sensitive Amine Oxidase and Vascular Adhesion Protein-1: One Protein Being Validated as a Therapeutic Target for Inflammatory Diseases
(I. McDonald, J. Foot, P. Yin, E. Flening, E. M. van Dam)
-Sphingosine 1-Phospate Type 1 Receptor Modulators: Recent Advances and Therapeutic
Potential (N. Cooke and Fr. Zecri)
-MAP Kinases Inhibitors in Inflammation and Autoimmune Disorders (S. Bhagwatt)
IV. Cancer and Infectious
Diseases
-Recent Progress on Novel HCV Inhibitors (C. W. Zapf, J. D. Bloom and J. I. Levin)
-Small Molecule CCR5 and CXCR4 Based Viral
Entry Inhibitors for anti-HIV therapy currently in development (W. W. Kazmierski, K. S. Gudmundsson and S. C. Piscitelli)
-Small-molecule
inhibitors of Gluthathione S-Transferase P1-1 as anticancer therapeutic agents. (G. Morales and E. Laborde)
-Recent Advances in the Medicinal
Chemistry of Histone Deacetylase Inhibitors (D. Brittain, H. Weinmann and E. Ottow)
-New Developments in Antibacterial Drug R&D (R. Frechette)
-Small Molecule Inhibitors of AKT/PKB Kinase As A Strategy for Treating Cancer (D. A. Heerding, I. G. Safonov and S. K. Verma)
V. Topics
in Biology
Spleen Tyrosine Kinase (Syk) Biology, Inhibitors and Therapeutic Applications (R. Singh, E. Masuda)
-Systems Biology and Kinase
Signaling (B. Gomes and D. de Graaf)
-The Molecular Libraries Screening Center Network (MLSCN): Identifying Chemical Probes of Biological
Systems (D. M. Huryn and N. D.P. Cosford)
-The Application of Transcriptional Profiling in Model Connectivity and Lead Assessment in
Drug Discovery (M. Neubauer and P. Ross-Macdonald)
VI. Topics in Drug Design and Discovery
-Fragment-based lead discovery (M. Congreve,
C. W. Murray, R. Carr and D. C. Rees)
-Computational Models for ADME (W. J. Egan)
-Prediction of human volume of distribution using in
vivo, in vitro, and in silio approaches (R. S. Obach)
Plasma Protein Binding and the Free Drug Principle: Recent Developments and Applications
(G. Trainer)
To Market, To Market 2006 (S. Hegde & M. Schmidt)
| Bibliographic details |
Paperback, 646 pages, publication date: NOV-2007
ISBN-13: 978-0-12-373912-4
ISBN-10: 0-12-373912-8
Imprint: ACADEMIC PRESS
|
| Price and Ordering |
Price:
USD 150
EUR 106.95
GBP 90.99
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
030/302
Last update: 9 Nov 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company